FDA Approves Generic Release of Abilify
Posted on May 1, 2015 by Rita Wilson
The U.S. Food and Drug Administration (FDA) approved the first AB-rated generics to Bristol-Myers Squibb and Otsuka’s Abilify® (aripiprazole) tablets, an atypical antipsychotic drug commonly used for treating schizophrenia and bipolar disorder. The agency approved generics from Alembic Pharmaceuticals, Hetero…
For Media Inquires, Contact:
Helen King Patterson
813.690.4787
helen@kingknight.com
Search our blog:
Contact Us for a FREE Consultation